Physician profile
Amy Mcghee
NPI 1275976417
$646.38
in general payments reported to CMS, 2019-2025
21 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $256 · 2021: $79.97 · 2022: $77.19 · 2023: $15.69 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.33 |
| Education | $103.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $175.22 | 2020-2025 | Imfinzi |
| Novartis Pharmaceuticals Corporation | $52.69 | 2022-2025 | |
| Genentech USA, INC. | $52.39 | 2021-2025 | Polivy |
| Amgen INC. | $45.22 | 2020 | |
| Puma Biotechnology, INC. | $42.18 | 2020 | |
| Abbvie INC. | $30.56 | 2025 | |
| Celgene Corporation | $28.57 | 2025 | Reblozyl |
| Tolmar Pharmaceuticals, INC. | $24.85 | 2021 | |
| Secura Bio, INC. | $23.05 | 2020-2022 | |
| Glaxosmithkline, LLC. | $18.82 | 2022 | |
| Beigene USA, INC. | $17.46 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.53 | 2020 | |
| Pfizer INC. | $15.69 | 2023 | |
| Pharmacyclics LLC, An Abbvie Company | $15.55 | 2020 | |
| Organon LLC | $14.74 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $13.76 | 2020 | |
| Sobi, INC | $13.75 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.02 | 2020 | |
| Incyte Corporation | $12.35 | 2021 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Clovis Oncology, INC. | $8.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mcghee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.